Skip to Main Content

Paper Details

DT2216-a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas.
J Hematol Oncol
59
2020
Author NameAffiliation
David M WeinstockDana-Farber Cancer Institute and Harvard Medical School
  • 1 - 1

Datasets

Release 1.2